Margaret Fitzpatrick Buys 2,098 Shares of Anthem (NASDAQ:ANTX) Stock

Anthem, Inc. (NASDAQ:ANTX) Director Margaret Fitzpatrick bought 2,098 shares of the stock in a transaction dated Tuesday, September 1st. The shares were bought at an average cost of $5.53 per share, with a total value of $11,601.94. Following the completion of the purchase, the director directly owned 10,708 shares of the company’s stock, valued at approximately $59,215.24. This trade represents a 24.37% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Anthem Stock Performance

NASDAQ ANTX opened at $5.95 on Friday. The stock has a market cap of $224.55 million, a PE ratio of -5.56 and a beta of -0.99. Anthem, Inc. has a 12 month low of $1.00 and a 12 month high of $7.19. The company’s 50-day moving average price is $5.28 and its 200-day moving average price is $4.31.

Anthem (NASDAQ:ANTX) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.18) earnings per share for the quarter.

Institutional Investors Weigh In On Anthem

Large investors have recently modified their holdings of the business. Vivo Capital LLC purchased a new position in Anthem during the first quarter valued at approximately $10,785,000. Seven Fleet Capital Management LP purchased a new stake in Anthem during the first quarter worth $683,000. Commodore Capital LP bought a new stake in Anthem during the 1st quarter valued at $7,981,000. Spruce Street Capital LP bought a new stake in Anthem during the 1st quarter valued at $5,576,000. Finally, Ally Bridge Group NY LLC purchased a new position in shares of Anthem in the 1st quarter valued at $1,800,000. Institutional investors own 90.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Anthem in a report on Monday, July 6th. Guggenheim assumed coverage on Anthem in a report on Monday, July 20th. They set a “buy” rating and a $9.00 price objective on the stock. Leerink Partners raised Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 target price for the company in a research report on Thursday, May 14th. Finally, Wall Street Zen upgraded Anthem from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Anthem presently has a consensus rating of “Hold” and an average target price of $9.00.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.